Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study

In the phase 3 LYM-3002 study comparing intravenous VR-CAP with R-CHOP in patients with newly-diagnosed, measurable stage II-IV mantle cell lymphoma, not considered or ineligible for transplant, the median progression-free survival was significantly improved with VR-CAP (24.7 versus 14.4 months with...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Gregor Verhoef, Tadeusz Robak, Huiqiang Huang, Halyna Pylypenko, Noppadol Siritanaratkul, Juliana Pereira, Johannes Drach, Jiri Mayer, Rumiko Okamoto, Lixia Pei, Brendan Rooney, Andrew Cakana, Helgi van de Velde, Franco Cavalli
Format:	Artigo
Język:	Inglês
Wydane:	Ferrata Storti Foundation 2017-05-01
Seria:	Haematologica
Dostęp online:	https://haematologica.org/article/view/8069
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!